<img height="1" width="1" alt="" style="display:none" src="https://www.facebook.com/tr?id=1455325778106062&amp;ev=PixelInitialized">
WEBINAR SERIES: May 14 & 28, 2024 | 9:00 am - 9:45 am CST     
Weight Loss Drugs
 

What Employers Need To Know About The Drugs and The Unexpected Cost Impact to Your Employee Benefits Program

LEARN MORE     SIGN UP

 

 

 

 

 

 
 
 
What is this event?
 

This is a 2-part educational series with a panel of industry experts. Originally developed to treat diabetes, GLP-1 Drugs like Ozempic, Wegovy, Mounjaro, Zepbound are now being touted in the media as “Obesity Drugs” because of their weight-loss effects. However, few are talking about the unexpected costs to health plans.

In 2023, U.S. demands for this category of pharmaceuticals exceeded supply, and some analysts predict the market could surpass $150 billion a year within a decade. Nearly 115 million U.S. adults and children are considered “obese” meaning over 30 million Americans could be using them. 

At a cost of $10,000 - $15,600 per year, these drugs could add 8-15% to health plan costs.

 
 
 
 
 
Who is this event for?
 
This program is for C-Suite individuals: CEO/President, CFO, CHRO, COO, HR and Benefits professionals.

 

 
The Impact of Weight Loss Drugs on Employer Health Care Costs 
             
Tuesday May 14, 2024 | Presented by Ryan Rice and Jeff Schultz

    • What is the net cost impact of GLP-1s to Health Plans?
    • What is the position of Pharmaceutical Benefits Managers (PBM)?
    • What should employers know about cost savings and budgeting?
 
The Risks, Side Effects, and Benefits of Weight Loss Drugs
             
Tuesday May 28, 2024 | Presented by Dr. Nichole Brady and Joseph Blatz
 
    • What are these drugs and how do they work?
    • What are the risks, side effects and clinical benefits?
    • What do studies show about who are using these drugs?
Join us and our panel of experts for this FREE 2-part educational series after which you'll come away with an understanding of the impact to health care costs and be better positioned to support your employees.

 

THE PRESENTERS
             
 
 

UHC_NikkiBrady_sq_w

 

Joe Blatz

 

 

 

Ryan Rice sq

 

Jeff Schultz sq

Dr. Nicole Brady

Chief Medical Officer, Michigan/Wisconsin United Healthcare Clinical Services

Dr. Nicole Brady is the Chief Medical Officer for UnitedHealthcare’s Employer and Individual business. In that role, she collaborates with providers to improve member experience and quality of care while innovating new care delivery models and payment methodologies that deliver greater value to members. She works with employers as they strive to improve the health and wellness of their employees while controlling costs. Dr. Brady is committed to ensuring individuals and communities have access to the highest quality, most cost-effective health care possible. 

She is a family physician who was born and raised in WI and enjoys spending time outdoors. She graduated from the Medical College of WI and UW Fox Valley Family Medicine Residency. She completed her MBA from Capella University. When she’s not at work, you can find her at her son and daughter’s sporting events, in the garden, on the lake or in the woods. 

Joseph Blatz

Regional Account Manager, Novo Nordisk

Joe Blatz has a successful track record working with Integrated Delivery Networks, Teaching Hospitals, Long-Term Care accounts, Payers/Regional PBM’s, Fortune 100 Employers, and Federal accounts. His 3 decades of diverse experience encompasses: Coaching, Mentoring, Cross Matrix Collaboration, Contract Negotiation, Team Building, and Building Strategic Relationships and Networks. His reputation for being able to map out a market and understand the connections has enabled him to be a successful strategic planner and help both his teams and customers achieve their goals.

In his role, Joe Blatz partners with Integrated Delivery Networks, Payers/Regional PBM’s, Coalitions, and Employers to support their chronic disease management efforts. He collaborates with local teams to strategically align resources to support opportunities in the Midwest Area markets.

Ryan Rice

President & Founder, The Prism Health Group

A graduate of Drake University, Ryan is the President and Founder of The Prism Health Group. Results driven, he is a proven healthcare professional, with demonstrated experience in new business development, strategic corporate development, and business operations. 

With a decade’s worth of industry experience, Ryan develops, aligns and empowers partnerships in the healthcare and pharmacy benefit management (PBM) industry.
 
With a primary focus with managed care, direct-to-employer, and TPA organizations, Ryan has worked closely with each client to outline effective, and highly custom methods of managing the pharmacy benefit to achieve leading plan cost savings and quality care for those they serve.

Jeff Schultz

Benefits Practice Leader, Acrisure Midwest

Jeff has 31 years of experience as an advisor to some of Wisconsin’s leading and most progressive employers. As the leader of our benefits practice, Jeff’s role is to guide our clients’ strategies and ensure they aren’t missing out on any opportunities to drive their health care strategy forward.

 
Register for the event:
 
Session 1 (May 14):
The Impact of Weight Loss Drugs on Employer Health Care Costs 
 
Session 2 (May 28):
The Risks, Side Effects, and Benefits of Weight Loss Drugs